Marketing and Safety Concerns for Compounded GLP-1 Receptor Agonists
T. Joseph Mattingly, Rena M. Conti
Abstract
This Viewpoint discusses supply and demand for glucagon-like peptide 1 (GLP-1) receptor agonists and concerns with using compounded drugs to fill this demand.
Topics & Concepts
BusinessGlucagon-like peptide 1 receptorReceptorAgonistMedicineInternal medicinePharmaceutical industry and healthcarePharmaceutical Economics and PolicyPharmaceutical Quality and Counterfeiting